4601 - 4625 of 8825 Results
Title
Year
- Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment2020OPENTitle: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 10End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00362-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00362-yCitation Count: 95
-
OPENTitle: Exercise Reverses Dysregulation of T-Cell-Related Function in Blood Leukocytes of Patients With Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page: 1389End Page: 1389Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2019.01389Best OA location URL: https://doi.org/10.3389/fneur.2019.01389Citation Count: 10
-
OPENTitle: Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological studyJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 667End Page: 667Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-14279-8Best OA location URL: https://escholarship.org/uc/item/2n48k3rkCitation Count: 477
-
OPENTitle: Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s diseaseJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 67End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-020-0401-2Best OA location URL: https://www.nature.com/articles/s41597-020-0401-2.pdfCitation Count: 109
-
OPENTitle: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of LevodopaJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/9716317Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/9716317.pdfCitation Count: 19
-
OPENTitle: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 2479End Page: 2479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-59414-4Best OA location URL: https://www.nature.com/articles/s41598-020-59414-4.pdfCitation Count: 100
-
OPENTitle: Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1839End Page: 1850Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27845Best OA location URL: http://hdl.handle.net/20.500.11820/51a559a5-38a4-4a09-a501-6c78ddefb3fdCitation Count: 188
-
OPENTitle: Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLsJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 2Start Page: e1008549End Page: e1008549Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1008549Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1008549&type=printableCitation Count: 29
-
OPENTitle: Differentiation of multiple system atrophy from Parkinson’s disease by structural connectivity derived from probabilistic tractographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 16488End Page: 16488Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-52829-8Best OA location URL: https://www.nature.com/articles/s41598-019-52829-8.pdfCitation Count: 44
-
OPENTitle: PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteinsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.50416Best OA location URL: https://doi.org/10.7554/elife.50416Citation Count: 137
-
OPENTitle: Parkinson’s disease prognostic scores for progression of cognitive declineJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 17485End Page: 17485Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-54029-wBest OA location URL: https://www.nature.com/articles/s41598-019-54029-w.pdfCitation Count: 17
-
OPENTitle: Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trialJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 93Issue #: 14Start Page: e1328End Page: e1338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008194Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6814412Citation Count: 43
-
OPENTitle: MR‐based age‐related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespanJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 18Start Page: 5269End Page: 5288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/hbm.24771Best OA location URL: https://doi.org/10.1002/hbm.24771Citation Count: 75
-
OPENTitle: Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive “low footprint” genetic knockout of alpha-synucleinJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 75End Page: 75Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-020-00613-5Best OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-020-00613-5Citation Count: 12
-
OPENTitle: Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic developmentJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 6970End Page: 6970Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-63559-7Best OA location URL: https://www.nature.com/articles/s41598-020-63559-7.pdfCitation Count: 76
-
OPENTitle: The turning and barrier course reveals gait parameters for detecting freezing of gait and measuring the efficacy of deep brain stimulationJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 4Start Page: e0231984End Page: e0231984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0231984Best OA location URL: https://doi.org/10.1371/journal.pone.0231984Citation Count: 43
-
OPENTitle: Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohortJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page: 192End Page: 192Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-020-01777-2Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-020-01777-2Citation Count: 21
- Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease2020OPENTitle: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 370End Page: 370Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00370Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00370/pdfCitation Count: 12
-
OPENTitle: Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 324End Page: 324Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00324Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00324/pdfCitation Count: 8
-
OPENTitle: Non-motor Clinical and Biomarker Predictors Enable High Cross-Validated Accuracy Detection of Early PD but Lesser Cross-Validated Accuracy Detection of Scans Without Evidence of Dopaminergic DeficitJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 364End Page: 364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00364Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00364/pdfCitation Count: 11
-
OPENTitle: Mitochondrial tRNA methylation in Alzheimer’s disease and progressive supranuclear palsyJournal Name: BMC Medical GenomicsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12920-020-0727-9Best OA location URL: https://bmcmedgenomics.biomedcentral.com/track/pdf/10.1186/s12920-020-0727-9Citation Count: 18
- Longitudinal follow-up with VIM thalamic deep brain stimulation for dystonic or essential tremor2020OPENTitle: Longitudinal follow-up with VIM thalamic deep brain stimulation for dystonic or essential tremorJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 10Start Page: e1073End Page: e1084Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008875Best OA location URL: https://n.neurology.org/content/neurology/94/10/e1073.full.pdfCitation Count: 83
-
OPENTitle: Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECTJournal Name: EJNMMI PhysicsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 34End Page: 34Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40658-020-00304-zBest OA location URL: https://ejnmmiphys.springeropen.com/track/pdf/10.1186/s40658-020-00304-zCitation Count: 21
-
OPENTitle: Microglial exosomes facilitate α-synuclein transmission in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 5Start Page: 1476End Page: 1497Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa090Best OA location URL: https://academic.oup.com/brain/article-pdf/143/5/1476/33281811/awaa090.pdfCitation Count: 501
-
OPENTitle: EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 543End Page: 558Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191841Best OA location URL: https://escholarship.org/uc/item/1vs1b0ctCitation Count: 35